Using its medicine supply map, USP determined ... prescription volume consists of generic drugs, with 35% made with APIs manufactured in India. USP’s supply chain breakdown is a stark reminder ...

According to the Food and Drug Administration (FDA), generic drugs ... the API supply is crucial to identifying vulnerabilities in the US pharmaceutical supply chain and identifying drugs that ...

There is a critical shortage of several inexpensive generic drugs (“Why Cancer ... other drug products that compete for the same supply chain and manufacturing facilities. The price differential ...

The instability of the generic drug supply chain has reached a crisis point. We now have shortages of critical medicines ranging from methotrexate for cancer therapy to amphetamine ...

This comes as supply chain AI company Exiger sounds the alarm ... He also said that the elderly and those who rely on critical generic drugs are most at risk of suffering from problems with ...

And in recent weeks, generic drug makers, supply-chain experts and patient advocates have appeared before lawmakers to discuss the problems. The scarcity of generic forms of chemotherapy to ...

Downward pressure on the price of generic drugs is playing a part in ... are further spotlighting systemic weaknesses in the supply chain that have been there for years,” said Dr de Jongh.

is working with a generic manufacturer, Hikma Pharmaceuticals, to supply pharmacies with the abiraterone prostate cancer treatment for $160 for a month’s supply. And the nonprofit is suggesting ...

The global supply chain for critical generic medicines faces increasing challenges. The skewed economics of the generic medicines market need to be corrected. About 80 per cent of the world’s ...

The economics of returning more generic drug manufacturing to the U.S. will be difficult, Fox said. "My main concern is the increasing fragility of the overall supply chain," Fox said. Some ...